GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Oventus Medical Ltd (ASX:OVN) » Definitions » Asset Turnover

Oventus Medical (ASX:OVN) Asset Turnover : 0.04 (As of Dec. 2021)


View and export this data going back to 2016. Start your Free Trial

What is Oventus Medical Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Oventus Medical's Revenue for the six months ended in Dec. 2021 was A$0.55 Mil. Oventus Medical's Total Assets for the quarter that ended in Dec. 2021 was A$12.47 Mil. Therefore, Oventus Medical's Asset Turnover for the quarter that ended in Dec. 2021 was 0.04.

Asset Turnover is linked to ROE % through Du Pont Formula. Oventus Medical's annualized ROE % for the quarter that ended in Dec. 2021 was -99.78%. It is also linked to ROA % through Du Pont Formula. Oventus Medical's annualized ROA % for the quarter that ended in Dec. 2021 was -82.44%.


Oventus Medical Asset Turnover Historical Data

The historical data trend for Oventus Medical's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oventus Medical Asset Turnover Chart

Oventus Medical Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21
Asset Turnover
0.03 0.02 0.03 0.04 0.07

Oventus Medical Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.04 0.04 0.04

Competitive Comparison of Oventus Medical's Asset Turnover

For the Medical Devices subindustry, Oventus Medical's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oventus Medical's Asset Turnover Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Oventus Medical's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Oventus Medical's Asset Turnover falls into.



Oventus Medical Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Oventus Medical's Asset Turnover for the fiscal year that ended in Jun. 2021 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Jun. 2021 )/( (Total Assets (A: Jun. 2020 )+Total Assets (A: Jun. 2021 ))/ count )
=1.09/( (14.327+15.079)/ 2 )
=1.09/14.703
=0.07

Oventus Medical's Asset Turnover for the quarter that ended in Dec. 2021 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2021 )/( (Total Assets (Q: Jun. 2021 )+Total Assets (Q: Dec. 2021 ))/ count )
=0.554/( (15.079+9.861)/ 2 )
=0.554/12.47
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Oventus Medical  (ASX:OVN) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Oventus Medical's annulized ROE % for the quarter that ended in Dec. 2021 is

ROE %**(Q: Dec. 2021 )
=Net Income/Total Stockholders Equity
=-10.28/10.303
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-10.28 / 1.108)*(1.108 / 12.47)*(12.47/ 10.303)
=Net Margin %*Asset Turnover*Equity Multiplier
=-927.8 %*0.0889*1.2103
=ROA %*Equity Multiplier
=-82.44 %*1.2103
=-99.78 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2021) net income data. The Revenue data used here is two times the semi-annual (Dec. 2021) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Oventus Medical's annulized ROA % for the quarter that ended in Dec. 2021 is

ROA %(Q: Dec. 2021 )
=Net Income/Total Assets
=-10.28/12.47
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-10.28 / 1.108)*(1.108 / 12.47)
=Net Margin %*Asset Turnover
=-927.8 %*0.0889
=-82.44 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2021) net income data. The Revenue data used here is two times the semi-annual (Dec. 2021) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Oventus Medical Asset Turnover Related Terms

Thank you for viewing the detailed overview of Oventus Medical's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Oventus Medical (ASX:OVN) Business Description

Traded in Other Exchanges
N/A
Address
1 Swann Road, Suite 1, PO Box 190, Indooroopilly, Brisbane, QLD, AUS, 4068
Oventus Medical Ltd is a medical device company. It is engaged in developing an oral appliance for the treatment of sleep apnoea and snoring. Its product includes O2Vent Optima . It offers oral appliance therapy, especially beneficial for the many people that suffer from nasal congestion, obstruction, and mouth breathing. The firm has two operating segments: Australia and North America.

Oventus Medical (ASX:OVN) Headlines

No Headlines